Home - Products - Others - Other Targets - Pinoresinol monomethyl ether 4-O-β-D-glucoside

Pinoresinol monomethyl ether 4-O-β-D-glucoside

CAS No. 74957-57-6

Pinoresinol monomethyl ether 4-O-β-D-glucoside( ——— )

Catalog No. M38272 CAS No. 74957-57-6

(+)-Pinoresinol monomethyl ether O-β-D-glucoside (Compound 6) is a natural product that can be isolated from the stems of Tinospora sinensis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pinoresinol monomethyl ether 4-O-β-D-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    (+)-Pinoresinol monomethyl ether O-β-D-glucoside (Compound 6) is a natural product that can be isolated from the stems of Tinospora sinensis.
  • Description
    (+)-Pinoresinol monomethyl ether 4-O-β-D-glucoside is a natural product.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    74957-57-6
  • Formula Weight
    534.552
  • Molecular Formula
    C27H34O11
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li W, et al. New lignan glucosides from the stems of Tinospora sinensis. Chem Pharm Bull (Tokyo). 2004 May;52(5):638-40.?
molnova catalog
related products
  • MethADP

    MethADP (Adenosine 5'-(α,β-methylene)diphosphate) is a specific CD73 inhibitor that inhibits the enzyme ecto-5′-nucleotidase (ecto), which has been used in the study of neurological and cardiovascular diseases.

  • β- Amyloid (1-16)

    β- Amyloid (1-16)

  • FFAGLDD TFA

    FFAGLDD TFA is an MMP9 selective cleavage peptide, which is used for the cytoplasmic transfer of doxorubicin (DOX) to realize the controlled slow drug delivery and release.